Sagility Limited — Q3 FY25 earnings call

Call held 5 Feb 2025

Management summary

Sagility delivered an exceptionally strong Q3 FY25, characterized by double-digit revenue growth and significant margin expansion. The quarter benefited from the 'open enrollment' season in the US healthcare market, which drove surge volumes. Management utilized its strong cash position to announce the strategic acquisition of BroadPath, aimed at diversifying the client base into the mid-market and adding member acquisition capabilities.

Highlights

  • Revenue reached ₹14,531 million ($172 million), up 15.3% YoY in INR terms and 14% in constant currency

  • Adjusted EBITDA margin stood at a record 31.4% for the quarter, driven by open enrollment seasonality

  • Consolidated Adjusted PAT grew 67.6% YoY to ₹2,626 million

  • Acquired BroadPath Healthcare Solutions for $58 million in an all-cash deal to expand mid-market presence

  • Provider vertical showed robust growth of 38% YoY, now contributing 10.7% of total revenue

  • Net debt including lease liabilities reduced to 0.55x of trailing 12 months EBITDA

  • Headcount increased to 39,595 with 1,215 employees added during the quarter to handle seasonal volumes

Key financials

  1. Revenue 14,531 Mn +15.3%YoY
  2. Adjusted EBITDA Margin 31.4%
  3. Adjusted PAT 2,626 Mn +67.6%YoY
  4. Attrition Rate 21.8%
  5. DSO 78 days

What they filed

Q1 FY27: revenue up 27.6%, net profit up 45.6% against the same quarter last year.

₹ Cr · quarterly
Line itemQ2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26Q4 FY26Q1 FY27
Revenue1,325 1,453 1,568 1,539 1,658 +25%1,971 +36%2,024 +29%1,963 +28%
EBITDA301 392 373 346 415 +38%511 +30%485 +30%438 +27%
Net profit117 217 183 149 251 +115%268 +24%258 +41%217 +46%
How to read this

₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.

Segment breakdown

SegmentRevenue ContributionYoY Growth
Payer Vertical89.3%13.1%
Provider Vertical10.7%38%

Guidance & targets

Margin

  • Steady State Adjusted EBITDA Margin Margin · Annual/Full Year · High confidence 24-25%
    If you look at on an annualised basis, the guidance that we gave around the 24%, 25% still continues to hold good, right?

    — Ramesh Gopalan, MD & Group CEO

  • BroadPath EBITDA Margin Improvement Margin · Next 2-3 years · Medium confidence 600-700 bps
    Over the next two, three years with purely from the synergies and improvement in efficiencies, we believe that those margins can move up 600, 700 basis points.

    — Ramesh Gopalan, MD & Group CEO

Revenue

  • Long-term Revenue Growth Revenue · Longer term · Medium confidence Low-to-mid-teens
    Overall, longer term, we believe that we will continue to grow in the low-to-mid-teens like we've committed.

    — Ramesh Gopalan, MD & Group CEO

  • FY25 Revenue Growth (INR) Revenue · FY25 · Medium confidence Similar to 9M YTD (15.3%)
    And looking at the full FY '25, we believe our growth will in INR terms will be very similar to the YTD growth for the nine months that you've seen.

    — Ramesh Gopalan, MD & Group CEO

Debt

  • Earnout Payments (Birch and DCI) Debt · FY26 · High confidence ₹348 million
    The adjustments on the EBITDA... they get over in FY '26. So in FY '25, we will have ₹486 million and the next year, its ₹348 million.

    — Sarvabhouman Srinivasan, Group CFO

Risks & concerns

  • Seasonality of Revenue and Margins

    medium

    Q3 and early Q4 are high-volume due to open enrollment; margins may dip in other quarters as ramp-up costs are incurred ahead of revenue.

    Management acknowledged

  • US Regulatory and Policy Changes

    medium

    Potential changes in Medicare payments or government healthcare spend under the new US administration could impact client budgets.

    Analyst acknowledged

  • Client Concentration

    low

    While top 10 clients are significant, management highlighted that BroadPath adds 30+ mid-market clients to diversify the base.

    Analyst downplayed

Areas of evasion (2)

  • Specific quantification of the open enrollment impact on margins vs underlying growth.
  • Specific growth rates for BroadPath over the last 2 years (cited COVID surge as making data non-indicative).

Q&A highlights

2 direct
Sustainability of 30%+ EBITDA Margins Direct
No. If you look at on an annualised basis, the guidance that we gave around the 24%, 25% still continues to hold good... Some quarters... will result in either margin increases or margin dips.

Clarifies that the current quarter's high margin is seasonal and not a new structural benchmark.

Asked by Manik Taneja, Axis Capital

BroadPath Acquisition Valuation and Margins Direct
We paid $58 million. All of it was funded in cash... the EBITDA margins are low double-digits... over the next two, three years... those margins can move up 600, 700 basis points.

Reveals the acquisition is margin-dilutive initially but offers significant synergy potential through offshoring and administrative cost reduction.

Asked by Ankur Pant, IIFL Securities

Impact of US Political Changes (Trump/Kennedy) Partial
As on date, we don't see anything that's going to impact our business, either positively or negatively... it's very premature for us to make a statement on that.

Management is cautious about predicting regulatory impacts but notes that healthcare remains highly regulated and labor-short, which favors outsourcing.

Asked by Deekshant Boolchandani, DB Wealth

2 min read 5 chapters

Detailed narrative

Open Enrollment Season Drives Record Margins

Sagility reported an Adjusted EBITDA margin of 31.4% in Q3 FY25, significantly higher than its steady-state guidance of 24-25%. This expansion was primarily driven by the 'open enrollment' season in the US, where insurers add or renew members, leading to a surge in high-margin volumes. Management noted that while they added 1,215 employees to handle this surge, the operational efficiencies and technology investments made in previous quarters flowed directly to the bottom line. Additionally, a ₹300 million FX gain further bolstered the quarterly margin profile.

Strategic Mid-Market Expansion via BroadPath

The acquisition of BroadPath Healthcare Solutions for $58 million marks a major step in Sagility's client diversification strategy. BroadPath brings over 30 mid-market clients and approximately $70 million in annual revenue, increasing Sagility's presence in the top 10 US payers from five to six. Although BroadPath currently operates at low double-digit EBITDA margins due to its onshore-heavy delivery model, Sagility plans to expand these margins by 600-700 basis points over the next 2-3 years through offshoring and administrative synergies.

Provider Vertical Outpaces Payer Growth

While the Payer vertical remains the dominant revenue contributor at 89.3%, the Provider business grew at a much faster rate of 38% YoY in Q3. Management attributed this to a smaller base and a conscious strategy to penetrate deeper into the provider segment. Unlike the Payer business, the Provider segment does not see significant benefits from the open enrollment season, indicating that its growth is driven by structural demand for healthcare services and operational excellence.

Strong Cash Generation and Debt Reduction

Sagility demonstrated robust cash flow generation, with operating cash flow of ₹9,132 million in the first nine months representing 94% of reported EBITDA. This strong cash position allowed the company to fund the BroadPath acquisition entirely through internal accruals. Furthermore, the company has consistently reduced its debt, with net debt (including lease liabilities) now standing at a healthy 0.55x of trailing 12-month EBITDA, which management expects will continue to enhance PAT margins through lower interest costs.

Navigating US Macro and Regulatory Landscape

Management addressed concerns regarding the new US administration and potential healthcare policy shifts. While acknowledging that healthcare is a highly regulated sector, they emphasized that labor shortages for clinicians and administrative staff in the US continue to drive the 'propensity to outsource.' They believe that even under cost pressure, clients are likely to move more work to partners like Sagility to achieve 30-60% savings compared to in-house operations. The company remains in a 'wait and watch' mode regarding specific policy changes like those from the Department of Government Efficiency (DOGE).

This is an AI-generated summary of a publicly available earnings call transcript.
View original transcript

More Information Technology earnings calls